ID
33487
Beschrijving
Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study; ODM derived from: https://clinicaltrials.gov/show/NCT01401400
Link
https://clinicaltrials.gov/show/NCT01401400
Trefwoorden
Versies (1)
- 11-12-18 11-12-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
11 december 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Chronic Hepatitis B NCT01401400
Eligibility Chronic Hepatitis B NCT01401400
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
HCV coinfection | Coinfection Hepatitis Delta Virus | HIV Coinfection
Datatype
boolean
Alias
- UMLS CUI [1]
- C1698259
- UMLS CUI [2,1]
- C0275524
- UMLS CUI [2,2]
- C0011220
- UMLS CUI [3]
- C4505456
Beschrijving
Immunosuppressive Agents | Chemotherapy | CORTICOSTEROIDS FOR SYSTEMIC USE | Prednisolone U/day | Prednisolone Equivalent
Datatype
boolean
Alias
- UMLS CUI [1]
- C0021081
- UMLS CUI [2]
- C0392920
- UMLS CUI [3]
- C3653708
- UMLS CUI [4,1]
- C0032950
- UMLS CUI [4,2]
- C0456683
- UMLS CUI [5,1]
- C0032950
- UMLS CUI [5,2]
- C0205163
Similar models
Eligibility Chronic Hepatitis B NCT01401400
- StudyEvent: Eligibility
C0149709 (UMLS CUI [2])
C1442989 (UMLS CUI [1,2])
C0021734 (UMLS CUI [2])
C0021735 (UMLS CUI [3])
C0391001 (UMLS CUI [4])
C0796545 (UMLS CUI [5])
C0449238 (UMLS CUI [1,2])
C0597107 (UMLS CUI [2])
C0279030 (UMLS CUI [3])
C0982327 (UMLS CUI [4])
C0009429 (UMLS CUI [5])
C0201483 (UMLS CUI [2])
C0275524 (UMLS CUI [2,1])
C0011220 (UMLS CUI [2,2])
C4505456 (UMLS CUI [3])
C0392920 (UMLS CUI [2])
C3653708 (UMLS CUI [3])
C0032950 (UMLS CUI [4,1])
C0456683 (UMLS CUI [4,2])
C0032950 (UMLS CUI [5,1])
C0205163 (UMLS CUI [5,2])